Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4712 (MIR4712) is a small non-coding RNA belonging to the class of microRNAs, which regulate gene expression post-transcriptionally by binding to complementary sequences on target messenger RNAs (mRNAs), leading to translational inhibition or mRNA degradation. MIR4712 has been shown to be upregulated in vulvar squamous cell carcinoma tissues and cell lines, where it promotes proliferation and invasion by directly targeting the tumor suppressor PTEN, thereby activating the AKT/cyclin D1 pathway. As with other miRNAs, dysregulation of MIR4712 can potentially contribute to pathological processes, most notably cancer[3][5]. There are no approved drugs known to target MIR4712 directly, but its expression level might be explored as a biomarker in relevant malignancies.
miRNA-mediated silencing of target mRNAs. Regulation of the PTEN/AKT/p-GSK3β/cyclin D1 signaling pathway (by targeting the tumor suppressor PTEN).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4712 (MIR4712).